Trichophyton indotineae

Emergence of resistant dermatophytosis caused by Trichophyton indotineae: First case series in Thailand

mycolabadmin

Researchers in Thailand have identified five patients with a difficult-to-treat fungal skin infection caused by Trichophyton indotineae, a type of dermatophyte that resists the commonly used antifungal drug terbinafine. This is the first time this resistant fungus has been detected in Thailand. The team developed a simple, inexpensive test using urease to help identify these resistant infections more easily. Patients responded well to the antifungal drug itraconazole after other treatments failed.

Spread of Antifungal-Resistant Trichophyton indotineae, United Kingdom, 2017–2024

mycolabadmin

A fungal infection called Trichophyton indotineae, which originated in Asia, is rapidly spreading throughout the United Kingdom and becoming resistant to common antifungal treatments. The infection typically starts in the groin area and can spread to other parts of the body, and many cases fail to respond to standard antifungal drugs like terbinafine. Researchers tracked 157 cases over seven years and found the fungus now accounts for over a third of all dermatophyte infections sent to the UK reference laboratory. Doctors and laboratory professionals are being urged to recognize this emerging threat and consider better diagnostic and treatment strategies.

Emergence of resistant dermatophytosis caused by Trichophyton indotineae: First case series in Thailand

mycolabadmin

Researchers in Thailand identified five patients with a new type of fungal skin infection caused by Trichophyton indotineae, a species that resists the common antifungal drug terbinafine. These infections appeared as rashes on various parts of the body and required treatment with alternative medications like itraconazole. The findings represent the first confirmed cases in Thailand and suggest this resistant fungus may be spreading globally. The study also showed that a simple urease test could help doctors identify this resistant strain quickly without waiting for complex genetic testing.

Spread of Antifungal-Resistant Trichophyton indotineae, United Kingdom, 2017–2024

mycolabadmin

A dangerous fungal infection called Trichophyton indotineae is rapidly spreading across the United Kingdom, particularly among people with connections to South Asia. This infection causes stubborn skin rashes that don’t respond well to common antifungal treatments like terbinafine. The number of cases has skyrocketed, making up 38% of all dermatophyte infections by 2024, and doctors need to be aware of this emerging threat.

Emergence of resistant dermatophytosis caused by Trichophyton indotineae: First case series in Thailand

mycolabadmin

Researchers in Thailand have identified the first cases of a new resistant fungal skin infection caused by Trichophyton indotineae. This fungus is resistant to a commonly used antifungal drug called terbinafine and causes persistent skin rashes on various body parts. The study describes five patients whose infections were finally identified through genetic testing and who responded well to alternative antifungal treatment with itraconazole. This discovery suggests the fungus is now spreading in Thailand and doctors should watch for it.

Emergence of resistant dermatophytosis caused by Trichophyton indotineae: First case series in Thailand

mycolabadmin

Doctors in Thailand have identified a new drug-resistant fungal infection caused by Trichophyton indotineae, a fungus that doesn’t respond to common antifungal medication terbinafine. Five patients were diagnosed with this resistant skin infection that caused rashes on various body parts and failed to improve with standard treatments. The research shows that a simple urease test can help doctors quickly identify this resistant fungus, and a different drug called itraconazole appears to work better for treatment. This is the first time this resistant fungus has been confirmed in Thailand, suggesting it is spreading globally.

Spread of Antifungal-Resistant Trichophyton indotineae, United Kingdom, 2017–2024

mycolabadmin

A highly resistant fungal infection called Trichophyton indotineae is rapidly spreading throughout the United Kingdom. Originally from southern Asia, this fungus causes difficult-to-treat skin infections, particularly in the groin area, and resists standard antifungal medications in about three-quarters of cases. Since 2023, cases have spread from London to other parts of the UK and Ireland, and experts predict it will soon become the leading cause of ringworm in the country.

Treatment and diagnostic challenges associated with the novel and rapidly emerging antifungal-resistant dermatophyte, Trichophyton indotineae

mycolabadmin

A new type of fungal infection called Trichophyton indotineae has emerged and spread globally, particularly from India. It causes widespread skin infections that are difficult to treat because the fungus resists common antifungal medications. Doctors and laboratories need to be aware of this infection to properly identify it and choose effective treatments, especially for patients with travel history to affected regions.

qPCR-Based Molecular Detection of Trichophyton indotineae by Targeting Divergent Sequences

mycolabadmin

Trichophyton indotineae is a dangerous fungal infection that causes ringworm and is increasingly resistant to common antifungal treatments. Scientists developed a rapid blood test-like diagnostic tool called qPCR that can accurately identify this specific fungus in less than 2 hours for just a few dollars. The test was created by comparing the genetic codes of different fungal species to find unique fingerprints that distinguish T. indotineae from similar-looking fungi.

Research Keyword: Trichophyton indotineae